ongoing

RADICAL PC – 2 is a randomized, controlled trial of a systematic approach to modifying cardiovascular and lifestyle risk factors in men with a new diagnosis of prostate cancer.

The primary objective of RADICAL PC – 2 is to determine whether a systematic cardiovascular and lifestyle risk factor modification strategy reduces the risk of major adverse cardiovascular events in men with a new diagnosis of prostate cancer or who are commencing Androgen Deprivation Therapy for the first time.

Study Type

Interventional - Procedure

Study Design

RCT

NO. of Countries

1

NO. of Sites

20

NO. of Participants

4600

Study Period

2015 - 2025

Sponsor

PHRI

Prostate Cancer Canada

Canadian Cancer Society

Hamilton Health Sciences

Back To Top